FDA: Compounding Pharmacies’ Arguments That Agency’s Actions Violated Law Fail
FORT WORTH, Texas — The U.S. Food and Drug Administration properly determined that the shortage of tirzepatide, an FDA-approved drug for diabetes and weight loss, had ended when it removed the...To view the full article, register now.
Already a subscriber? Click here to view full article